Cargando…

Diffusion tensor imaging changes in patients with glioma-associated seizures

INTRODUCTION: Structural white matter changes associated with certain epilepsy subtypes have been demonstrated using diffusion tensor imaging (DTI). This observational study aims to identify potential water diffusion abnormalities in glioma patients with associated seizures. METHODS: Two cohorts fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mader, Marius Marc-Daniel, Deuter, Daniel, Sauvigny, Thomas, Borchert, Patrick, Faizy, Tobias D., Bester, Maxim, Westphal, Manfred, Rosengarth, Katharina, Schmidt, Nils O., Sedlacik, Jan, Dührsen, Lasse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722813/
https://www.ncbi.nlm.nih.gov/pubmed/36344852
http://dx.doi.org/10.1007/s11060-022-04139-9
_version_ 1784844039329153024
author Mader, Marius Marc-Daniel
Deuter, Daniel
Sauvigny, Thomas
Borchert, Patrick
Faizy, Tobias D.
Bester, Maxim
Westphal, Manfred
Rosengarth, Katharina
Schmidt, Nils O.
Sedlacik, Jan
Dührsen, Lasse
author_facet Mader, Marius Marc-Daniel
Deuter, Daniel
Sauvigny, Thomas
Borchert, Patrick
Faizy, Tobias D.
Bester, Maxim
Westphal, Manfred
Rosengarth, Katharina
Schmidt, Nils O.
Sedlacik, Jan
Dührsen, Lasse
author_sort Mader, Marius Marc-Daniel
collection PubMed
description INTRODUCTION: Structural white matter changes associated with certain epilepsy subtypes have been demonstrated using diffusion tensor imaging (DTI). This observational study aims to identify potential water diffusion abnormalities in glioma patients with associated seizures. METHODS: Two cohorts from two centers were analyzed independently: (A) Prospectively recruited patients diagnosed with glioma who received preoperative DTI to measure mean diffusivity (MD) and fractional anisotropy (FA) in regions-of-interest (ROIs) including the marginal tumor zone (TU), adjacent peritumoral white matter as well as distant ipsilateral and contralateral white matter and cortex. Data were compared between patients with and without seizures and tested for statistical significance. (B) A retrospective cohort using an alternative technical approach sampling ROIs in contrast enhancement, necrosis, non-enhancing tumor, marginal non-enhancing tumor zone, peritumoral tissue, edema and non-tumorous tissue. RESULTS: (A) The prospective study cohort consisted of 23 patients with 12 (52.2%) presenting with a history of seizures. There were no significant seizure-associated differences in MD or FA for non-tumor white matter or cortical areas. MD-TU was significantly lower in patients with seizures (p = 0.005). (B) In the retrospective cohort consisting of 46 patients with a seizure incidence of 50.0%, significantly decreased normalized values of MD were observed for non-enhancing tumor regions of non-glioblastoma multiforme (GBM) cases in patients with seizures (p = 0.022). CONCLUSION: DTI analyses in glioma patients demonstrated seizure-associated diffusion restrictions in certain tumor-related areas. No other structural abnormalities in adjacent or distant white matter or cortical regions were detected. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11060-022-04139-9.
format Online
Article
Text
id pubmed-9722813
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-97228132022-12-07 Diffusion tensor imaging changes in patients with glioma-associated seizures Mader, Marius Marc-Daniel Deuter, Daniel Sauvigny, Thomas Borchert, Patrick Faizy, Tobias D. Bester, Maxim Westphal, Manfred Rosengarth, Katharina Schmidt, Nils O. Sedlacik, Jan Dührsen, Lasse J Neurooncol Case Study INTRODUCTION: Structural white matter changes associated with certain epilepsy subtypes have been demonstrated using diffusion tensor imaging (DTI). This observational study aims to identify potential water diffusion abnormalities in glioma patients with associated seizures. METHODS: Two cohorts from two centers were analyzed independently: (A) Prospectively recruited patients diagnosed with glioma who received preoperative DTI to measure mean diffusivity (MD) and fractional anisotropy (FA) in regions-of-interest (ROIs) including the marginal tumor zone (TU), adjacent peritumoral white matter as well as distant ipsilateral and contralateral white matter and cortex. Data were compared between patients with and without seizures and tested for statistical significance. (B) A retrospective cohort using an alternative technical approach sampling ROIs in contrast enhancement, necrosis, non-enhancing tumor, marginal non-enhancing tumor zone, peritumoral tissue, edema and non-tumorous tissue. RESULTS: (A) The prospective study cohort consisted of 23 patients with 12 (52.2%) presenting with a history of seizures. There were no significant seizure-associated differences in MD or FA for non-tumor white matter or cortical areas. MD-TU was significantly lower in patients with seizures (p = 0.005). (B) In the retrospective cohort consisting of 46 patients with a seizure incidence of 50.0%, significantly decreased normalized values of MD were observed for non-enhancing tumor regions of non-glioblastoma multiforme (GBM) cases in patients with seizures (p = 0.022). CONCLUSION: DTI analyses in glioma patients demonstrated seizure-associated diffusion restrictions in certain tumor-related areas. No other structural abnormalities in adjacent or distant white matter or cortical regions were detected. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11060-022-04139-9. Springer US 2022-11-07 2022 /pmc/articles/PMC9722813/ /pubmed/36344852 http://dx.doi.org/10.1007/s11060-022-04139-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Study
Mader, Marius Marc-Daniel
Deuter, Daniel
Sauvigny, Thomas
Borchert, Patrick
Faizy, Tobias D.
Bester, Maxim
Westphal, Manfred
Rosengarth, Katharina
Schmidt, Nils O.
Sedlacik, Jan
Dührsen, Lasse
Diffusion tensor imaging changes in patients with glioma-associated seizures
title Diffusion tensor imaging changes in patients with glioma-associated seizures
title_full Diffusion tensor imaging changes in patients with glioma-associated seizures
title_fullStr Diffusion tensor imaging changes in patients with glioma-associated seizures
title_full_unstemmed Diffusion tensor imaging changes in patients with glioma-associated seizures
title_short Diffusion tensor imaging changes in patients with glioma-associated seizures
title_sort diffusion tensor imaging changes in patients with glioma-associated seizures
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722813/
https://www.ncbi.nlm.nih.gov/pubmed/36344852
http://dx.doi.org/10.1007/s11060-022-04139-9
work_keys_str_mv AT madermariusmarcdaniel diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures
AT deuterdaniel diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures
AT sauvignythomas diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures
AT borchertpatrick diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures
AT faizytobiasd diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures
AT bestermaxim diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures
AT westphalmanfred diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures
AT rosengarthkatharina diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures
AT schmidtnilso diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures
AT sedlacikjan diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures
AT duhrsenlasse diffusiontensorimagingchangesinpatientswithgliomaassociatedseizures